Production (Stage)
ESSA Pharma Inc.
EPIX
$1.67
-$0.03-1.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -9.69% | 89.85% | 82.41% | 20.26% | 15.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.65% | 27.52% | 7.64% | -3.06% | 27.79% |
| Operating Income | 29.65% | -27.52% | -7.64% | 3.06% | -27.79% |
| Income Before Tax | 29.09% | -43.05% | -15.94% | 0.89% | -27.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.09% | -43.05% | -15.94% | 0.89% | -27.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.09% | -43.05% | -15.94% | 0.89% | -27.33% |
| EBIT | 29.65% | -27.52% | -7.64% | 3.06% | -27.79% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 29.33% | -42.16% | -15.21% | 1.51% | -26.92% |
| Normalized Basic EPS | 29.29% | -42.13% | -15.19% | 1.55% | -26.87% |
| EPS Diluted | 29.33% | -42.16% | -15.21% | 1.51% | -26.92% |
| Normalized Diluted EPS | 29.29% | -42.13% | -15.19% | 1.55% | -26.87% |
| Average Basic Shares Outstanding | 0.34% | 0.59% | 0.62% | 0.62% | 0.33% |
| Average Diluted Shares Outstanding | 0.34% | 0.59% | 0.62% | 0.62% | 0.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |